HY-13438-1mL
|
MedChemexpress LLC
|
AZD3839 (free base) [CAS 1227163-84-9] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-111925-1mg
|
MedChemexpress LLC
|
BI-749327 [CAS 2361241-23-6]
|
|
COVID-19-immunoregulation
|
|
HY-111925-10mg
|
MedChemexpress LLC
|
BI-749327 [CAS 2361241-23-6]
|
|
COVID-19-immunoregulation
|
|
HY-111925-100mg
|
MedChemexpress LLC
|
BI-749327 [CAS 2361241-23-6]
|
|
COVID-19-immunoregulation
|
|
HY-111925-5mg
|
MedChemexpress LLC
|
BI-749327 [CAS 2361241-23-6]
|
|
COVID-19-immunoregulation
|
|
HY-111925-50mg
|
MedChemexpress LLC
|
BI-749327 [CAS 2361241-23-6]
|
|
COVID-19-immunoregulation
|
|
HY-111925-1mL
|
MedChemexpress LLC
|
BI-749327 [CAS 2361241-23-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-P1256C-5mg
|
MedChemexpress LLC
|
JMV 449 (acetate) [CAS 141863-45-8]
|
|
Neuroscience-Neuromodulation
|
|